Increased levels of GFAP protein has been identified in the blood samples of patients suffering from neurological diseases, such as Parkinson's disease (13), intracerebral hemorrhage (14, 18), traumatic spinal cord injury (19), and multiple sclerosis (15). The gene discussed is GFAP; the disease is nervous system disorder.